Seeking Alpha
 

Par Pharmaceutical Companies, Inc. (PRX)

- Pending
  • Aug. 2, 2012, 10:32 AM
    Par Pharmaceutical (PRX): Q2 EPS of $1.62 beats by $0.52. Revenue of $294.3M (+36.9% Y/Y) beats by $3.M. (PR)
    | Aug. 2, 2012, 10:32 AM | Comment!
  • Aug. 2, 2012, 12:05 AM
    Notable earnings before Thursday’s open: AEE, APA, ARIA, BDX, CAH, CI, CNP, DNR, DTV, DUK, ENB, GM, INCY, K, MFA, NNN, OCN, PGN, PH, PRX, PWR, PXP, RDC, SBH, SE, SEE, SHO, SNE, SRE, TDC, TE, TEVA, TIE, TWC, UPL, VIAB, VRX, WNR, XEL
    | Aug. 2, 2012, 12:05 AM | Comment!
  • Aug. 1, 2012, 5:30 PM
    Notable earnings before Thursday’s open: AEE, APA, ARIA, BDX, CAH, CI, CNP, DNR, DTV, DUK, ENB, GM, INCY, K, MFA, NNN, OCN, PGN, PH, PRX, PWR, PXP, RDC, SBH, SE, SEE, SHO, SNE, SRE, TDC, TE, TEVA, TIE, TWC, UPL, VIAB, VRX, WNR, XEL
    | Aug. 1, 2012, 5:30 PM | Comment!
  • May 8, 2012, 8:24 AM
    Pharmaceutical Resources (PRX): Q1 EPS of $0.80 beats by $0.08. Revenue of $272M (+17% Y/Y) beats by $42M. (PR)
    | May 8, 2012, 8:24 AM | Comment!
  • Feb. 28, 2012, 8:34 AM
    Pharmaceutical Resources (PRX): Q4 EPS of $0.78 beats by $0.04. Revenue of $254M (+11.7% Y/Y) beats by $24M. (PR)
    | Feb. 28, 2012, 8:34 AM | Comment!
Visit Seeking Alpha's
PRX vs. ETF Alternatives
Company Description
Sector: Healthcare
Industry: Drugs - Generic
Country: United States